ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 235 filers reported holding ARGENX SE in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $622,268 | +22.0% | 1,447 | +11.7% | 0.00% | +33.3% |
| Q1 2024 | $509,867 | -13.7% | 1,295 | -16.6% | 0.00% | -25.0% |
| Q4 2023 | $590,808 | -14.6% | 1,553 | +10.4% | 0.00% | -20.0% |
| Q3 2023 | $691,723 | +41.0% | 1,407 | +11.8% | 0.01% | +25.0% |
| Q2 2023 | $490,670 | -3.5% | 1,259 | -7.8% | 0.00% | 0.0% |
| Q1 2023 | $508,572 | +19.1% | 1,365 | +21.2% | 0.00% | +33.3% |
| Q4 2022 | $427,000 | -1.8% | 1,126 | -8.5% | 0.00% | -25.0% |
| Q3 2022 | $435,000 | -25.1% | 1,231 | -19.7% | 0.00% | -20.0% |
| Q2 2022 | $581,000 | +24.4% | 1,533 | +3.5% | 0.01% | +66.7% |
| Q1 2022 | $467,000 | -3.3% | 1,481 | +7.4% | 0.00% | 0.0% |
| Q4 2021 | $483,000 | +64.3% | 1,379 | +41.6% | 0.00% | +50.0% |
| Q3 2021 | $294,000 | +9.7% | 974 | +9.3% | 0.00% | 0.0% |
| Q2 2021 | $268,000 | – | 891 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 285,198 | $106,259,071 | 29.06% |
| Avoro Capital Advisors LLC | 1,287,500 | $479,696,750 | 7.11% |
| Paradigm Biocapital Advisors LP | 181,172 | $67,501,064 | 6.40% |
| DCF Advisers, LLC | 25,700 | $9,575,310 | 5.86% |
| Artia Global Partners LP | 36,404 | $13,563,402 | 5.01% |
| Bellevue Group AG | 886,928 | $330,451,634 | 4.80% |
| Fairmount Funds Management LLC | 73,526 | $27,394,317 | 4.71% |
| Eagle Health Investments LP | 64,400 | $23,994,152 | 4.67% |
| Decheng Capital Management III (Cayman), LLC | 27,429 | $10,219,497 | 4.12% |
| RTW INVESTMENTS, LP | 482,195 | $179,656,213 | 3.74% |